Souza dos Santos; Robson Augusto

Patent Applications and Registrations

Patent applications and USPTO patent grants for Souza dos Santos; Robson Augusto.The latest application filed is for "process for preparing amphiphilic peptide derivatives".

Company Profile

0.6.7

Souza dos Santos; Robson Augusto - Belo Horizonte N/A BR
Souza Dos Santos; Robson Augusto - Belo Horizente BR
Souza Dos Santos; Robson Augusto - Belo Horizente MG BR
Souza Dos Santos; Robson Augusto - Belo Horizonte-MG BR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Peptides Des-[Asp.sup.1]-[Ala.sup.1], angiotensin-(1-7) agonist and pharmaceutical compositions for the treatment of diseases Grant 9,974,825 - Souza dos Santos , et al. May 22, 2	2018-05-22
Process For Preparing Amphiphilic Peptide Derivatives App 20160168224 - BRAGA; Janaina Felix ; et al.	2016-06-16
Angiotensin Peptide and Pharmaceutical Compositions for Disease Treatment App 20160122387 - Souza Dos Santos; Robson Augusto ; et al.	2016-05-05
Process for the preparation of compositions of AT1 receptor antagonist and Angiotensin--(1-7) Grant 8,653,031 - Sinisterra Millan , et al. February 18, 2	2014-02-18
Method for modulating, treating and/or preventing metabolic syndrome using MAS-G-protein-coupled receptor agonists Grant 8,586,054 - Souza Dos Santos , et al. November 19, 2	2013-11-19
Peptides Des-[asp1]-[ala1], Angiotensin-(1-7) Agonist And Pharmaceutical Compositions For The Treatment Of Diseases App 20130183367 - Souza dos Santos; Robson Augusto ; et al.	2013-07-18
Process For The Preparation Of Compositions Of At1 Receptor Antagonist And Angiotensin-(1-7) App 20100144624 - SinisterraMillan; Ruben Dario ; et al.	2010-06-10
Use of Mas-G-Protein-Coupled Receptor Agonists in the Treatment of the Metabolic Syndrome, Its Components and its Complications App 20090221498 - Souza Dos Santos; Robson Augusto ; et al.	2009-09-03
Use of Mas G-Protein-Coupled Receptor Agonists and Antagonists, as Apoptotic-Activity Modulators for Study, Prevention and Treatment of Diseases App 20080312129 - Souza Dos Santos; Robson Augusto ; et al.	2008-12-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.